Oxidized low-density lipoprotein sensitizes human vascular smooth muscle cells to Fas (CD95)-mediated apoptosis

Clinical and Experimental Pharmacology and Physiology

Volumn 30, Issue 4, 2003, Pages 289-294

  Takarada, Shigeho ^a   Imanishi, Toshio ^a   Hano, Takuzo ^a   Nishio, Ichiro ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Fas; Fas ligand; Oxidized low density lipoprotein; Vascular smooth muscle cells

Indexed keywords

BENZYLOXYCARBONYLPHENYLALANYLALANYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; DNA FRAGMENT; FAS ANTIBODY; FAS ANTIGEN; FAS LIGAND; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEASOME; UBIQUITIN;

AORTA MEDIA; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; FETUS; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

AMINO ACID CHLOROMETHYL KETONES; ANTIBODIES; ANTIGENS, CD95; AORTA; APOPTOSIS; CASPASES; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; DNA FRAGMENTATION; EMBRYO; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEUPEPTINS; LIPOPROTEINS, LDL; MULTIENZYME COMPLEXES; MUSCLE, SMOOTH, VASCULAR; PROTEASOME ENDOPEPTIDASE COMPLEX; UP-REGULATION;

EID: 0037391532     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2003.03829.x     Document Type: Article

References (33)

1. Yla-Herttuala S, Palinski W, Rosenfeld ME et al. Evidence for the presence of oxidatively modified low-density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest, 1989; 84: 1086-95.
2. Witztum JL, Steinberg D. Role of oxidized low-density lipoprotein in atherogenesis. J. Clin. Invest. 1991; 88: 1785-92.
3. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801-9.
4. Dimmeler S, Haendeler J, Galle J, Zeiher AM. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: A mechanistic clue to the 'response to injury' hypothesis. Circulation 1995; 95: 1760-3.
5. Jovinge S, Crisby M, Thyberg J, Nilsson J. DNA fragmentation and ultrastructural changes of degenerating cells in atherosclerotic lesions and smooth muscle cells exposed to oxidized LDL in vitro. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2225-31.
6. Harada-Shiba M, Kinoshita M, Kamido H, Shimokado K. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J. Biol. Chem. 1998; 273: 9681-7.
7. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 1995; 95: 2266-74.
8. Bjorkerud S, Bjorkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am. J. Pathol. 1996; 149: 367-80.
9. Pollman MJ, Hall JL, Mann MJ, Zhang LN, Gibbons GH. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat. Med. 1998; 4: 222-7.
10. Sata M, Walsh K. Oxidized LDL activates Fas-mediated endothelial cell apoptosis. J. Clin. Invest. 1998; 102: 1682-9.
11. Sata M, Suhara T, Walsh K. Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand in sensitivity to Fas ligand-induced cell death. Arterioscler. Thromb. Vasc. Biol. 2000; 20: 309-16.
12. Cai W, Devaux B, Schaper W, Schaper J. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis 1997; 131: 177-86.
13. Geng YJ, Henderson LE, Levesque EB, Muszynski M, Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2200-8.
14. Dong C, Wilson JE, Winters GL, McManus BM. Human transplant coronary disease: Pathological evidence for Fas-mediated apoptotic cytotoxity in allograft arteriopathy. Lab. Invest. 1996; 74: 921-31.
15. Sara M, Walsh K. TNFα regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nat. Med. 1998; 4: 415-20.
16. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-56.
17. French L, Hahne M, Viard G et al. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell. Biol. 1996; 133: 335-43.
18. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189-92.
19. Ogasawara J, Watanabe-Fukunaga R, Adachi M et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364: 806-9.
20. Imanishi T, Hano T, Nishio I, Liles WC, Schwartz SM, Han DKM. Transition of apoptotic resistant vascular smooth muscle cells to troptotic sensitive state is correlated with downregulation of c-FLIP. J. Vasc. Res. 2000; 37: 523-31.
21. Geng YJ, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-γ, tumor necrosis factor-α, and interleukin-1β. Arterioscler. Thromb. Vasc. Biol. 1996; 16: 19-27.
22. Meiners S, Laule M, Rother W, Stangl K Ubiquitin-proteasome pathway as a new target for the prevention of restenosis. Circulation 2002; 105: 483-9.
23. Vieira O, Salvayre R, Negre-Salvayre A. Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: Potential role in oxidized induced apoptosis. FASEB J. 2000; 14: 532-42.
24. Heinecke JW, Baker L, Rosen H, Chait A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J. Clin. Invest. 1986; 77: 757-61.
25. Enari M, Hase A, Nagata S. Apoptosis by a cytosolic extract from Fasactivated cells. EMBO J. 1995; 14: 5201-8.
26. Bennett M, Macdonald K, Chan S-W, Luzio JP, Simari R, Weissberg P. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis. Science 1998; 282: 290-3.
27. Berliner JA, Navab M, Fogelman AM et al. Atherosclerosis: Basic mechanism. Oxidation, inflammation and genetics. Circulation 1995; 91: 2488-96.
28. Nishio E, Arimura S, Watanabe Y. Oxidized LDL induces apoptosis in cultured smooth muscle cells: A possible role for 7-ketocholesterol. Biochem. Biophys. Res. Commun. 1996; 223: 413-18.
29. Reid VC, Hardwick MJ, Mitchinson MJ. Fragmentation of DNA in P388D1 macrophages exposed to oxidized low-density lipoprotein. FEBS Lett. 1993; 332: 218-20.
30. Reid VC, Mitchinson MJ, Skepper JN. Cytotoxity of oxidized low-density lipoprotein to mouse peritoneal macrophages: An ultrastructural study. J. Pathol. 1993; 171: 321-8.
31. Tewari M, Quan LT, O'Rourke K et al. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 1995; 81: 801-9.
32. Tewari M, Dixit VM. Fas- and tumor necrosis factor-induced apoptosis is inhibited by poxvirus crmA gene product. J. Biol. Chem. 1995; 270: 3255-60.
33. Itoh N, Yonehara S, Ishii A et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediated apoptosis. Cell 1991; 66: 233-43.